Concepedia

David Durrant

DD

Statistics

Publications

36

Citations

2K

H-Index

22

Active since

2003

Affiliations

Virginia Commonwealth University(Current)

University of Ferrara

University of Utah

Huntsman Cancer Institute

Frederick National Laboratory for Cancer Research

David Durrant is an author at Virginia Commonwealth University specializing in pharmacology, medicine, and life sciences.

ORCID

Publications per year

2003–2022

36

Publications

36

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

Anindita Das, David Durrant, Clint Mitchell et al. · Proceedings of the National Academy of Sciences · 2010 · 161 citations

, , +15

Mammalian Target of Rapamycin (mTOR) Inhibition with Rapamycin Improves Cardiac Function in Type 2 Diabetic Mice

Anindita Das, David Durrant, Saisudha Koka et al. · Journal of Biological Chemistry · 2013 · 151 citations · Full text

, , +17

Phospholipid scramblase 3 controls mitochondrial structure, function, and apoptotic response.

Jihua Liu, Qiang Dai, Jun Chen et al. · PubMed · 2003 · 139 citations

, , +17

Structural insights into the BRAF monomer-to-dimer transition mediated by RAS binding

Juliana A. Martinez Fiesco, David Durrant, Deborah K. Morrison et al. · Nature Communications · 2022 · 138 citations · Full text

, , +17

Rapamycin protects against myocardial ischemia–reperfusion injury through JAK2–STAT3 signaling pathway

Anindita Das, Fadi N. Salloum, David Durrant et al. · Journal of Molecular and Cellular Cardiology · 2012 · 128 citations

, , +14

1–5 of 36